Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
SNARE proteins: Core engines of membrane fusion in cancer
Biochimica Et Biophysica Acta Reviews on Cancer
October 2026
Liu H.
Open Access
Neuroscience in prostate cancer
Prostate Cancer and Prostatic Diseases
September 2026
Liu Z.
Open Access
Botulinum Neurotoxin-A Inhibits Tumor Growth in a Triple-Negative Breast Cancer Preclinical Model
Toxins
May 2026
Lopez E.N.
Open Access
From Microbes to Medicine: Bacteriotherapy's Emerging Role in Cancer Treatment Strategies
Current Cancer Therapy Reviews
2026
Goel A.
Innovative horizons: harnessing drug repositioning for targeted therapeutics in colorectal cancer
Naunyn Schmiedeberg S Archives of Pharmacology
December 2025
Tarin M.
Cytotoxic and molecular effects of captopril on a colon cancer cell-line: an in vitro study
Pharmakeftiki
10 October 2025
Al-Saady T.A.
Mechanism of botulinum toxin type A in the treatment of axillary hyperhidrosis
Chinese Journal of Plastic Surgery
25 June 2025
Liu L.
Pioneering pain management with botulinum toxin type A: From anti-inflammation to regenerative therapies
Heliyon
28 February 2025
Rahmatipour H.
Open Access
Several first-line anti-hypertensives act on fibrosarcoma progression and PD1ab blockade therapy
Journal of Orthopaedic Surgery and Research
December 2024
Sun J.
Open Access
Drug Repurposing for Cancer Treatment: A Comprehensive Review
International Journal of Molecular Sciences
November 2024
Al Khzem A.H.
Open Access
The Potential Therapeutic Effects of Botulinum Neurotoxins on Neoplastic Cells: A Comprehensive Review of In Vitro and In Vivo Studies
Toxins
August 2024
Safarpour D.
Open Access
Anticancer Potential of ACEIs/ARBs Administration in Colorectal Cancer
Current Medicinal Chemistry
2024
Wang X.
Therapeutic Applications of Snake Venom Proteins as Anti-cancer Agents
Molecular Biomarkers for Cancer Diagnosis and Therapy
1 January 2024
Zabidi N.Z.
Computational Insights into Captopril’s Inhibitory Potential Against MMP9 and LCN2 in Bladder Cancer: Implications for Therapeutic Application
Cancer Informatics
January-December 2024
Annana S.K.
Botulinum Toxin Treatment for Cancer-Related Disorders: A Systematic Review
Toxins
December 2023
Safarpour D.
Open Access
Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
Cancers
June 2023
Hijazi M.A.
Open Access
Multidimensional role of bacteria in cancer: Mechanisms insight, diagnostic, preventive and therapeutic potential
Seminars in Cancer Biology
November 2022
Mughal M.J.
Bacteria and tumor: Understanding the roles of bacteria in tumor genesis and immunology
Microbiological Research
August 2022
Zhao M.
Open Access
In-vitro Preliminary Evaluation of Antioxidant and Anticoagulant Activity of Novel N-Phenyl Hydrazine 1-Carbothioamide Derivatives of (2-Methyl-3-(Substituted Thio)Propanoyl) Proline
International Journal of Drug Delivery Technology
July-September 2022
Najeh A.H.
Open Access
Role of TRPM2 in brain tumours and potential as a drug target
Acta Pharmacologica Sinica
April 2022
Ji D.
Open Access
Botulinum toxin in cancer therapy—current perspectives and limitations
Applied Microbiology and Biotechnology
January 2022
Grenda T.
Open Access
Bradykinin-Potentiating Peptide-Paclitaxel Conjugate Directed at Ectopically Expressed Angiotensin-Converting Enzyme in Triple-Negative Breast Cancer
Journal of Medicinal Chemistry
9 December 2021
Guo X.M.
All Open Access, Green
A proline-based tectons and supramolecular synthons for drug design 2.0: A case study of acei
Pharmaceuticals
November 2020
Bojarska J.
Open Access